Crown Holdings
CCK
$97.16
+1.12%
Crown Holdings Inc. is a global producer of metal packaging, manufacturing beverage cans, metal food cans, closures, and aerosol cans, and has expanded into protective transport packaging through its Signode acquisition, operating within the Consumer Cyclical sector's Packaging & Containers industry. The company is a major global player in metal packaging, distinct for its significant international footprint with the vast majority of sales derived from Europe, South America, and Southeast Asia. The current investor narrative is shaped by a defensive rotation towards essential, non-cyclical packaging businesses with strong cash flows, as highlighted in recent news, coupled with the company's recent move to aggressively raise its dividend to attract yield-focused investors in a higher interest rate environment.…
CCK
Crown Holdings
$97.16
Related headlines
Investment Opinion: Should I buy CCK Today?
Rating: Hold. The core thesis is that CCK is a financially leveraged, cash-generative business in a defensive industry facing severe but potentially transient margin pressure, making it a speculative turnaround bet at current valuations rather than a clear-cut opportunity.
Supporting evidence includes a deeply discounted forward P/E of 10.87x versus the trailing 16.16x, a robust FCF yield supported by $1.098B in TTM FCF, and analyst expectations for an EPS recovery to $9.50. However, these positives are counterbalanced by the gross margin collapsing to 10.30%, a 3-month price decline of 13.28% indicating negative momentum, and a debt-to-equity ratio of 2.06 that limits financial flexibility.
The thesis would upgrade to a Buy if gross margins demonstrate a clear recovery back above 15% in the next quarter, confirming the compression was temporary, or if the price approaches the 52-week low of $89.21, offering a greater margin of safety. It would downgrade to a Sell if Q4 margins represent a new normal, leading to consensus EPS cuts below $8.00, or if the stock breaks decisively below its 52-week low. Relative to its own history and the defensive nature of its cash flows, the stock appears fairly valued to slightly undervalued, but the valuation is justified by the significant operational risks.
Sign up to view all
CCK 12-Month Price Forecast
CCK presents a classic 'show me' story. The valuation is undemanding and the free cash flow generation is impressive, which supports a Hold rating for patient investors. However, the severe and sudden deterioration in profitability cannot be ignored and dominates the near-term risk. The stance is neutral, leaning cautiously optimistic if margins show any sign of bottoming. This would upgrade to bullish on evidence of margin recovery in the next quarterly report. Conversely, another quarter of sub-12% gross margins would likely warrant a downgrade to bearish, as it would confirm a structural impairment to the business model.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crown Holdings's 12-month outlook, with a consensus price target around $126.31 and implied upside of +30.0% versus the current price.
Average Target
$126.31
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$78 - $126
Analyst target range
Analyst coverage is limited with only 7 analysts providing estimates, indicating this is not a widely followed large-cap name, which can lead to higher volatility and less efficient price discovery. The available data shows a consensus estimated EPS of $9.50 for the upcoming period, with a range from $8.74 to $10.51, but crucially, data on specific price targets, buy/hold/sell ratings, and the implied upside from the current price are not available in the provided dataset, preventing a detailed sentiment analysis. The lack of explicit target prices and recommendation distribution suggests investors must rely more heavily on their own fundamental and valuation work, with the recent institutional rating actions showing a mix of maintained Outperform/Buy ratings and one notable downgrade from Overweight to Neutral by JP Morgan in early February 2026.
Bulls vs Bears: CCK Investment Factors
The evidence currently tilts bearish due to the severe and recent deterioration in profitability, which is the most concrete and damaging data point. The sharp gross margin collapse from 18.94% to 10.30% quarter-over-quarter directly undermines the defensive cash flow narrative. However, compelling bullish factors exist, primarily the deep valuation discount and robust FCF generation. The single most important tension in the investment debate is whether the severe margin compression is a temporary, fixable issue or a structural problem that will persist. The resolution of this margin question will determine if the stock's low multiples represent a value trap or a compelling opportunity.
Bullish
- Strong Free Cash Flow Generation: The company generated $1.098 billion in trailing twelve-month free cash flow, providing a robust FCF yield and ample internal funding. This supports the recent aggressive dividend increase and provides a defensive cushion for debt reduction and shareholder returns.
- Attractive Forward Valuation: With a forward P/E of 10.87x, the stock is priced for a significant earnings recovery, trading at a deep discount to its own historical trailing P/E of 16.16x. The low EV/Sales of 1.36x and P/S of 0.96x suggest the market has priced in substantial pessimism.
- Defensive Business Model & Low Beta: The essential nature of metal packaging provides non-cyclical demand, as highlighted in recent news. A beta of 0.646 indicates the stock is about 35% less volatile than the market, offering downside protection in turbulent markets.
- Aggressive Dividend Hike for Yield: The company recently announced a significant dividend increase to attract yield-focused investors in a higher rate environment, signaling management confidence in its cash flow stability and commitment to shareholder returns.
Bearish
- Severe and Accelerating Margin Compression: Gross margin collapsed to 10.30% in Q4 2025 from 18.94% in Q3 2025, and net income fell to $149M from $358M YoY. This indicates acute pressure from input costs, pricing, or mix, threatening the core profitability thesis.
- Pronounced Technical Downtrend & Weakness: The stock is down 13.28% over 3 months and 8.40% over 1 month, significantly underperforming the SPY by -21.70 and -14.00 points respectively. Trading at 82% of its 52-week range near $96.08 signals persistent selling pressure and broken momentum.
- Inconsistent Revenue Growth & Demand Softness: While Q4 revenue grew 7.72% YoY to $3.127B, it declined sequentially from Q3's $3.202B. This volatile pattern, coupled with a high concentration of sales in Europe, South America, and Asia, exposes the business to regional economic headwinds.
- Elevated Financial Leverage: A debt-to-equity ratio of 2.06 indicates a leveraged balance sheet. While FCF is strong, sustained margin pressure could strain the company's ability to comfortably service debt while funding dividends and growth.
CCK Technical Analysis
The stock is in a pronounced downtrend, having declined 13.28% over the past three months and 8.40% over the past month, significantly underperforming the broader market which saw gains of 8.42% and 5.6% over the same periods, respectively. Currently trading at $96.08, the price sits at approximately 82% of its 52-week range (between $89.21 and $116.62), indicating it is much closer to its yearly lows than highs, which suggests a potential value opportunity but also reflects persistent selling pressure and negative momentum. Recent momentum is decisively negative and accelerating the longer-term downtrend, with the 1-month decline of 8.40% far exceeding the 1-year loss of 3.51%, signaling a breakdown from previous consolidation and a potential capitulation phase, further evidenced by a significant relative strength deficit of -13.99 points against the SPY over the past month. Key technical support is firmly established at the 52-week low of $89.21, while resistance lies at the recent highs near $116, and a sustained break below support would likely trigger further downside, whereas the stock's low beta of 0.646 indicates it is about 35% less volatile than the market, which may provide some downside cushion but also limits upside beta during recoveries.
Beta
0.65
0.65x market volatility
Max Drawdown
-17.3%
Largest decline past year
52-Week Range
$89-$117
Price range past year
Annual Return
-2.3%
Cumulative gain past year
| Period | CCK Return | S&P 500 |
|---|---|---|
| 1m | -9.3% | +4.0% |
| 3m | -11.9% | +8.2% |
| 6m | +2.6% | +11.5% |
| 1y | -2.3% | +24.3% |
| ytd | -6.7% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CCK Fundamental Analysis
Revenue growth has been inconsistent, with the most recent quarterly revenue of $3.127 billion representing a 7.72% year-over-year increase, but this follows a volatile pattern where the prior quarter (Q3 2025) saw a sequential decline to $3.202 billion from $3.149 billion in Q2, indicating potential demand softness or pricing pressures in certain segments. The company remains profitable with net income of $149 million in Q4 2025, but profitability has compressed significantly from the year-ago quarter's $358 million, and the gross margin of 10.30% in the latest quarter is a stark contraction from the 18.94% margin in Q3 2025, highlighting severe margin pressure likely from input cost inflation or unfavorable product mix. The balance sheet shows a leveraged but cash-generative profile, with a debt-to-equity ratio of 2.06 and a current ratio of 1.03 indicating adequate short-term liquidity, while the company generated substantial trailing twelve-month free cash flow of $1.098 billion, providing strong internal funding for dividends, buybacks, and debt reduction, as evidenced by a robust FCF yield.
Quarterly Revenue
$3.1B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.10%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CCK Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE stands at 16.16x, while the forward PE is significantly lower at 10.87x, indicating the market expects a meaningful recovery in earnings over the next twelve months. Compared to its own historical range, the current trailing PE of 16.16x sits well below the higher end of its recent historical band, which has seen peaks above 35x, suggesting the stock is trading at a discount to its own historical valuation, potentially pricing in the recent margin compression and growth concerns. The stock trades at a significant discount on a sales basis as well, with a PS ratio of 0.96x and an EV/Sales of 1.36x, which are low multiples for a global industrial business, reflecting investor skepticism about future growth and return on capital.
PE
16.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -16x~86x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are centered on severe profitability erosion. The gross margin collapse from 18.94% to 10.30% in one quarter is alarming and, if sustained, would cripple earnings power despite $1.098B in TTM FCF. The debt-to-equity ratio of 2.06 adds leverage risk if margins do not recover. Revenue concentration outside the U.S. (Europe, South America, Southeast Asia) exposes the company to regional recessions and currency volatility, as seen in the inconsistent quarterly revenue trend from $3.202B to $3.127B sequentially.
Market & Competitive Risks include valuation compression despite already low multiples. The forward P/E of 10.87x discounts a recovery; if earnings disappoint, the multiple could expand downward. The stock's low beta of 0.646, while defensive, also limits upside participation in market rallies, as evidenced by its -28.70 point relative underperformance vs. the SPY over one year. Competitive pressures in metal packaging and potential substitution by alternative materials could cap long-term growth and pricing power, making margin recovery more difficult.
Worst-Case Scenario involves the Q4 margin collapse proving structural rather than cyclical, leading to a downward revision of the $9.50 consensus EPS estimate. Combined with a regional economic downturn in its key markets, this could trigger a re-rating to a deeper valuation discount, pushing the stock toward its 52-week low of $89.21. A realistic downside from the current $96.08 is approximately -7% to this technical support level, but a breach could lead to a fall toward the $80s, representing a potential loss of 15-20% if sentiment turns decisively negative and the dividend hike fails to attract support.
FAQ
The primary risk is operational: the severe gross margin compression from 18.94% to 10.30% quarter-over-quarter, which threatens profitability. Financial risk stems from a leveraged balance sheet with a debt-to-equity ratio of 2.06. Market risk includes the stock's persistent downtrend, having underperformed the SPY by over 21 points in 3 months, indicating poor sentiment. Competitive/geographic risk involves revenue concentration in Europe, South America, and Asia, exposing it to regional economic slowdowns.
The 12-month outlook presents three scenarios. The base case (55% probability) sees a range of $100-$110, assuming margin stabilization and modest EPS growth. The bull case (25%) targets $117-$125 on a successful margin recovery and earnings beat. The bear case (20%) risks a fall to the $89-$95 range if margin weakness persists. The most likely outcome is the base case, where the stock muddles through as the company works to fix its profitability issues, with the dividend providing some support.
CCK appears fairly valued to slightly undervalued based on forward earnings, but the discount is justified by operational risks. The forward P/E of 10.87x is a deep discount to its own trailing P/E of 16.16x, suggesting the market expects an earnings rebound. Low sales multiples (P/S of 0.96x, EV/Sales of 1.36x) also indicate pessimism. The valuation implies the market expects the recent margin weakness to be temporary; if it's permanent, the stock could still be overvalued.
CCK is a speculative buy, not a clear-cut good buy. It may be suitable for value-oriented, patient investors seeking a turnaround in a defensive business. The forward P/E of 10.87x is attractive, and the strong $1.098B free cash flow provides a margin of safety. However, the severe gross margin collapse to 10.30% represents a major risk that must be resolved. It could be a good buy for those who believe margins will recover, but it carries significant downside if they do not.
CCK is more suitable for a medium-to-long-term investment horizon (2+ years). The low beta of 0.646 suggests it's not a high-volatility trading vehicle for short-term gains. The investment thesis revolves around a operational turnaround and margin recovery, which will take multiple quarters to confirm. The recently increased dividend also adds an income component better suited for longer-term holders. Short-term traders would be betting on technical bounces, which is risky given the clear downtrend and lack of near-term catalysts.